Lv1
30 积分 2025-03-17 加入
A Practical Guide to the Pearls and Pitfalls of PSMA PET Imaging
14小时前
已完结
PARP inhibitors in prostate cancer: clinical applications
26天前
已完结
Advances in diagnosis and treatment of bladder cancer
26天前
已完结
Advances in diagnosis and treatment of testicular cancer
27天前
已完结
Metastatic Hormone-Sensitive Prostate Cancer and Combination Treatment Outcomes
27天前
已完结
[Expert consensus on homologous recombination repair gene testing and variant interpretation in prostate cancer]
1个月前
已完结
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 Update
1个月前
已完结
ARNEO: A Randomized Phase II Trial of Neoadjuvant Degarelix with or Without Apalutamide Prior to Radical Prostatectomy for High-risk Prostate Cancer
1个月前
已完结
Medication-associated orbital inflammation: A systematic review
1个月前
已完结
Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial
1个月前
已完结
皖公网安备34019202002308
